Anna D. Garrett, PharmD, BCPS, CPP
Published Online: Friday, September 1, 2006

The Stroke Council of the American Heart Association (AHA) recently updated its 1999 strokeprevention guidelines. The guidelines are evidencebased, and recommendations are given a grade based on the strength of the evidence that supports them. The new recommendations suggest that transient ischemic attack (TIA) and stroke be treated in an equally aggressive manner. The authors also recommend an approach that reduces the risk of all vascular events. Recommendations regarding management of risk factors related to comorbidities (hypertension, diabetes, and lipids) and lifestyle issues (smoking, physical activity, and alcohol) are included as well.

The new guidelines issue the strongest recommendations for the following:

  • Antiplatelet therapy for noncardioembolic stroke or TIA
  • Warfarin therapy for atrial fibrillation
  • Carotid endarterectomy for large artery atherosclerosis
  • Statin therapy
  • Antihypertensive therapy
  • Diabetes control

The updated guidelines can be accessed on the AHA's Web site,

Dr. Garrett is a clinical pharmacist practitioner at Cornerstone Health Care in High Point, NC.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues